Medicinal Chemistry

Creating next-gen drug molecules

About us

Find out more about the Medicinal Chemistry theme.

Research groups

Our research groups work with a wide range of collaborators within and external to Monash to develop molecules to treat disease.

Research areas

Discover more about our major areas of expertise, including chemical biology and G-protein coupled receptor drug discovery.

PhD programs

Discover what a higher degree with us entails and find out about available projects.

Capabilities and research platforms

Learn more about the techniques we employ and the tools we use.

Laptop use

Contact us

For any enquiries please contact Nicki Penny at +61 3 9903 9614 or nicki.penny@monash.edu.

Latest news from Medicinal Chemistry

New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch

This work is the result of a collaboration between medicinal chemists, laboratory and clinician scientists at Monash University and Peter MacCallum Cancer Centre.
4 September, 2023 Medicine & health
Dr Arisbel Batista Gondin and Dr Chris Smedley

Early career researchers awarded nearly $1m in funding

Dr Arisbel Batista Gondin and Dr Chris Smedley from MIPS are recipients of the 2024 ARC Discovery Early Career Researcher Award (DECRA) scheme
30 August, 2023 Research
A person working in a medicinal chemistry laboratory

Professor Brendon Monahan joins MIPS as Director of MedChem Australia

Prior to joining MIPS, Brendon was the Chief Scientific Officer of Canthera Discovery.
20 July, 2023 Research
Professor Paul Stupple, Professor Sue Charman Professor Guillaume Lessene, Dr Jeff Mitchell, Professor Michael Kassiou, Dr Stuart Newman

MRFF backs new national venture to strengthen homegrown medicine outcomes

The Commonwealth Government’s Medical Research Future Fund (MRFF) National Critical Research Infrastructure Grant has invested $9.75 million into establishing MedChem Australia.
26 June, 2023 Medicine & health
person wearing a white lab coat performing chemistry experiments in a fume hood

Drug discovery platform receives funding, providing a new approach for infectious and chronic disease treatments

The MIPS group will focus on responding to the risk of viral and bacterial replication through the development of a platform capability in polynucleotide fragment based drug design that is better able to discover small-molecules for targeting RNA
1 June, 2023 Medicine & health
Paul Stupple

Professor Paul Stupple appointed Director of the ATMCF

From the age of 14, Professor Paul Stupple knew he wanted to be a medicinal chemist and go on to work for a large pharmaceutical company. In 2000 Professor Stupple achieved his lifelong goal when he joined Pfizer, an experience that enabled him to
2 February, 2023 Medicine & health

Antibiotic Discovered at Monash Shows Promising Results in Clinical Trials

QPX9003, a novel antibiotic developed by Monash University researchers targeting antibiotic-resistant ‘superbugs’ has achieved an important milestone in its clinical development, with the initial Phase 1 studies of the drug delivering
8 November, 2022 Medicine & health

MRFF grant to fund research into novel epilepsy drugs

A Monash-led team of researchers has been funded $3.8 million in the current round of Medical Research Future Fund to develop a new class of drug compounds to counter drug-resistant epilepsy.
5 October, 2022 Medicine & health
HIV infecting human cell

Burnet teams up with Monash and BioCurate to develop novel HIV antivirals

Burnet Institute, in collaboration with MIPS has received Proof of Concept funding from BioCurate to develop next-generation HIV antivirals.
4 August, 2022 Medicine & health

Other research themes